Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Neoadjuvant therapy with an aromatase inhibitor and durvalumab in postmenopausal patients with hormone receptor-positive breast cancer.
Journal: Breast cancer research and treatment
Published: July 07, 2025
A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes.
Journal: Breast cancer (Dove Medical Press)
Published: May 04, 2022
IRIS METASTASIS FROM BREAST CANCER SUCCESSFULLY TREATED WITH ABEMACICLIB AND LETROZOLE.
Journal: Retinal cases & brief reports
Published: June 15, 2021
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia.
Journal: Cancer medicine
Published: April 08, 2020
Durable Complete Response With Immune Checkpoint Inhibitor in Breast Cancer With High Tumor Mutational Burden and APOBEC Signature.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 10, 2019
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2018
Showing 1-6 of 6
Last Updated: 09/26/2026